Amgen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slid 0.78% to $232.29 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.17% to 4,130.62 and Dow Jones Industrial Average falling 0.66% to 33,309.51.
This was the stock's fourth consecutive day of losses.
Amgen Inc. closed $64.38 below its 52-week high ($296.67), which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.41% to $160.99 and Pfizer Inc. (PFE) fell 0.82% to $37.58.
Trading volume (1.6 M) remained 674,000 below its 50-day average volume of 2.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 11, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 11, 2023 16:37 ET (20:37 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.